We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+47.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$540M
AUM Growth
+$30.8M
(+6%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-13.15%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
405
New
161
Increased
21
Reduced
59
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Digital
APLD
|
+$4.62M |
| 2 |
WW
WW International
WW
|
+$3.97M |
| 3 |
Harmonic Inc
HLIT
|
+$3.58M |
| 4 |
SI-BONE Inc
SIBN
|
+$3.34M |
| 5 |
Tactile Systems Technology
TCMD
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$5.66M |
| 2 |
Harrow
HROW
|
+$5.57M |
| 3 |
Impinj
PI
|
+$5.06M |
| 4 |
Ceco Environmental
CECO
|
+$4.79M |
| 5 |
Par Pacific Holdings
PARR
|
+$4.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.89% |
| 2 | Technology | 25.18% |
| 3 | Industrials | 23.68% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Consumer Staples | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Immunovant
IMVT
$8.2B
| $755K | 0.14% |
+39,796
| New | +$742K |
|
252
NeoGenomics
NEO
$2B
| $737K | 0.14% |
45,855
-83,117
| -64% | -$1.37M |
|
|
KWY
253
Kingsway Corp
KWY
$260M
| $548K | 0.1% |
67,270
-110,088
| -62% | -$941K |
|
254
Achieve Life Sciences
ACHV
$672M
| $477K | 0.09% |
+91,963
| New | +$645K |
|
|
ITI
255
DELISTED
Iteris, Inc.
ITI
| $420K | 0.08% |
106,156
-180,299
| -63% | -$805K |
|
256
Protalix BioTherapeutics
PLX
$197M
| $331K | 0.06% |
+165,631
| New | +$395K |
|
257
Asbury Automotive
ABG
$3.88B
| – | – |
-6,762
| Closed | -$1.42M |
|
258
Agilysys
AGYS
$3.03B
| – | – |
-52,635
| Closed | -$4.34M |
|
259
Applied Industrial Technologies
AIT
$13.3B
| – | – |
-16,971
| Closed | -$2.41M |
|
260
Aldeyra Therapeutics
ALDX
$95.9M
| – | – |
-211,388
| Closed | -$2.1M |
|
261
Alamo Group
ALG
$2.02B
| – | – |
-15,679
| Closed | -$2.89M |
|
262
Allegro MicroSystems
ALGM
$7.91B
| – | – |
-42,382
| Closed | -$2.03M |
|
263
Alta Equipment Group
ALTG
$240M
| – | – |
-101,922
| Closed | -$1.62M |
|
264
AutoNation
AN
$6.99B
| – | – |
-10,448
| Closed | -$1.4M |
|
265
Ardelyx
ARDX
$1.2B
| – | – |
-685,903
| Closed | -$3.29M |
|
266
Archrock
AROC
$5.84B
| – | – |
-232,679
| Closed | -$2.27M |
|
267
Ardmore Shipping
ASC
$695M
| – | – |
-131,996
| Closed | -$1.96M |
|
268
Academy Sports + Outdoors
ASO
$2.94B
| – | – |
-32,336
| Closed | -$2.11M |
|
269
Asure Software
ASUR
$252M
| – | – |
-139,551
| Closed | -$2.02M |
|
270
ATI
ATI
$30.5B
| – | – |
-51,700
| Closed | -$2.04M |
|
271
Atkore
ATKR
$3.16B
| – | – |
-17,192
| Closed | -$2.42M |
|
|
ATXS
272
DELISTED
Astria Therapeutics
ATXS
| – | – |
-72,129
| Closed | -$959K |
|
273
Aurinia Pharmaceuticals
AUPH
$2.07B
| – | – |
-82,453
| Closed | -$904K |
|
274
Aviat Networks
AVNW
$272M
| – | – |
-54,560
| Closed | -$1.88M |
|
275
Concrete Pumping Holdings
BBCP
$488M
| – | – |
-187,814
| Closed | -$1.28M |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q2 2023 Portfolio in Review
As of Q2 2023, EAM Investors held 405 positions worth $540M, up 6% from $509M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
EAM Investors withdrew a net $71M in Q2 2023, closing 149 positions and reducing 59 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.66M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Applied Digital worth $7.24M.
- EAM Investors's largest Q2 2023 buy was Applied Digital: 774,423 shares worth $7.24M.
- EAM Investors added most to Arlo Technologies in Q2 2023, an estimated $2.35M increase.
- EAM Investors's biggest Q2 2023 reduction was Harrow, cutting an estimated $5.57M.
- EAM Investors fully exited Viking Therapeutics in Q2 2023, selling an estimated $5.66M.
- EAM Investors's ten largest holdings make up 9.8% of its $540M portfolio in Q2 2023.
- EAM Investors opened 161 new positions and closed 149 in Q2 2023.
- EAM Investors's portfolio value rose 6% quarter-over-quarter to $540M.
Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.